Drugs / BCG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04362124 | Aug 2020 → Jun 2021 | COVID-19 | Universidad de Antioquia | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04362124 ↗ |
| Action | Activate | “can activate the human immune system in a broad way” NCT04362124 ↗ |
| Modality | Vaccine | “BCG vaccine” NCT04362124 ↗ |